levothyroxine sodium 0.075 MG Oral Tablet LevoT
1 INDICATIONS AND USAGE LEVO-T is L-thyroxine (T 4 ) indicated for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. ( 1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. ( 1 ) Limitations of Use: - not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. - Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Hypothyroidism LEVO-T is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression LEVO-T is indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: LEVO-T is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with LEVO-T may induce hyperthyroidism [see Warnings and Precautions (5.4) ]. LEVO-T is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
Neolpharma, Inc.
OVAL PURPLE GG 333 75
Related Pills
levothyroxine sodium 75 MCG Oral Tablet
Sandoz Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING LEVO-T (
LEVOTHYROXINE SODIUM, USP) tablets are supplied as follows: Strength (mcg) Color/Shape Tablet Markings NDC# for bottles of 90 NDC # for bottles of 1000 25 orange/Caplet "25" and "GG/331" 55466-104-11 55466-104-19 50 white/ Caplet "50" and "GG/332" 55466-105-11 55466-105-19 75 violet/ Caplet "75" and "GG/333" 55466-106-11 55466-106-19 88 olive green/ Caplet "88" and 'GG/334" 55466-107-11 -- 100 yellow/ Caplet "100" and "GG/335" 55466-108-11 55466-108-19 112 Rose/ Caplet "112" and "GG/336" 55466-109-11 -- 125 brown/ Caplet "125" and "GG/337" 55466-110-11 55466-110-19 137 turquoise/ Caplet "137" and "GG/330" 55466-111-11 -- 150 blue/ Caplet "150" and "GG/338" 55466-112-11 -- 175 lilac/ Caplet "175" and "GG/339" 55466-113-11 -- 200 pink/ Caplet "200" and "GG/340" 55466-114-11 -- 300 green/ Caplet "300" and "GG/341" 55466-115-11 -- Storage Conditions Store at 25°C (77°F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. LEVO-T tablets should be protected from light and moisture.
More pills like OVAL GG 333 75